COVID-19 and diabetes: understanding the interrelationship and risks for a severe course

CP Landstra, EJP de Koning - Frontiers in endocrinology, 2021 - frontiersin.org
The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional.
On the one hand, diabetes mellitus is considered one of the most important risk factors for a …

Thiazolidinediones: the forgotten diabetes medications

HE Lebovitz - Current diabetes reports, 2019 - Springer
Abstract Purpose of Review Thiazolidinediones (TZDs) are the only pharmacologic agents
that specifically treat insulin resistance. The beneficial effects of TZDs on the cardiovascular …

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on …

CW Yancy, M Jessup, B Bozkurt, J Butler… - Journal of the American …, 2013 - jacc.org
2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …

Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association

RL Page, CL O'Bryant, D Cheng, TJ Dow, B Ky… - Circulation, 2016 - Am Heart Assoc
Heart failure is a common, costly, and debilitating syndrome that is associated with a highly
complex drug regimen, a large number of comorbidities, and a large and often disparate …

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart …

CW Yancy, M Jessup, B Bozkurt, J Butler, DE Casey Jr… - Circulation, 2013 - Am Heart Assoc
The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2011 and includes selected …

Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways

K Huynh, BC Bernardo, JR McMullen… - Pharmacology & …, 2014 - Elsevier
Cardiovascular disease is the primary cause of morbidity and mortality among the diabetic
population. Both experimental and clinical evidence suggest that diabetic subjects are …

Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies

D Aune, T Feng, S Schlesinger, I Janszky… - Journal of Diabetes and …, 2018 - Elsevier
Background Diabetes and elevated blood glucose have been associated with increased risk
of atrial fibrillation in a number of epidemiological studies, however, the findings have not …

Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy

RE Gilbert, H Krum - The Lancet, 2015 - thelancet.com
Individuals with diabetes are not only at high risk of developing heart failure but are also at
increased risk of dying from it. Fortunately, antiheart failure therapies such as angiotensin …

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ–modulating activity

SC Benson, HA Pershadsingh, CI Ho, A Chittiboyina… - …, 2004 - Am Heart Assoc
The metabolic syndrome is a common precursor of cardiovascular disease and type 2
diabetes that is characterized by the clustering of insulin resistance, dyslipidemia, and …

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association

RW Nesto, D Bell, RO Bonow, V Fonseca, SM Grundy… - Circulation, 2003 - Am Heart Assoc
occur over time during TZD treatment. Patients with type 2 diabetes who have significant
underlying asymptomatic heart disease may also be prescribed these drugs, even though …